[
    "1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30.31.32.33.34.35.36.37.38.39.40.41.42.43.44.45.46.47.48.50.51.52.53.54.55.56.57.58.59.60.61.62.63.64.65.66.67.68.69.70.71.72.73.74.75.76.78.79.80.81.82.83.84.85.86.87.88.89.90.91.92.93.94.95.96.97.98.99.99",
    "1.4 U.Wandl Sperra do commons la za zamlo",
    "Fig. 1 (A) Cyclic voltammograms of 1a and 2a in CH3CN at 100 mV s-1scan rates. (B) Cyclic voltamograms of la in CH2CN at different scanrates. Curves were obtained at 80, 90, 100, 120, 160, 180, 200, 220, 280and 300 mv s -1, respectively. (C) The plot of the peak current vs. scanrate. (D) The relationship between Epa and Inv. (E) Cyclic voltammo-grams of 2a In CH3CN at different scan rates.Curves were obtained at60, 70,90, 140,180, 220 and 280 mV v s - 1,respectively. (F) Theplot ofthe peak current vS. scan rate. (G) The relationships between Epa and In v.",
    "Fig. 3 Electrostatic potential (ESP)25 of 1a. The ESP mapping wascarried out using the Multiwfn Version 37/dev26 and VMD version 1.9.3programs.27",
    "Scheme 1 Synthetr methods for the sublimation of impregnations",
    "Scheme 2 The substrate scope of 2-arylimidazol(1,2-alpyridines andsodium sulfinates. Reaction conditions: 1 (0.3 mmol), 2 (3 equiv).CH3CN/H2O (7 mL), constant current = 5 mA, undivided cell, under air atroom temperature for 9 h, isolated yields. 6 h. 7 h. '8 h. 3aa as a by-product was isolated in 40% yield.",
    "Scheme 3 Control experiments.",
    "Scheme 4 The proposed mechanism.",
    "Scheme 5 The extended experiments of Sma",
    "Table 1 Optimization of the reaction conditions",
    "Table 2 Absorption, emission and fluorescence quantum yields (of) ofcompounds 1a, Saa, 7 and 9\u00ba\u00ba"
]